NCJ Number
182782
Date Published
August 1998
Length
185 pages
Annotation
This report presents the findings of a 5-year experimental study of drug testing for youthful offenders released to parole.
Abstract
The study's intent was to determine how much drug testing should be part of regular parole supervision. For juveniles committed to the California Youth Authority (CYA), parole follows a determination by the Youthful Offender Parole Board (YOPB) that the offender has made sufficient progress to warrant release into the community. Youthful parolees are not, for the most part, "drug offenders," but are serious offenders who also have substance abuse problems. Drug testing is believed to reduce drug use among offenders through deterrence and detection. This study was designed to assess differences in outcome (if any) for comparable groups that differed in the amount of drug testing but not in other aspects of supervision. By maximizing scientific rigor, the study sought to obtain the best assessment of the effectiveness of drug testing levels, independent of the effects of other aspects of parole supervision. The sample included all wards committed directly to the CYA from juvenile or adult courts who were released to parole over the course of 10 months (November 1992 through August 1993). The study found that positive drug tests during the first 3 months of parole predicted higher levels of arrest over the follow-up period up to 42 months. These results suggest that drug testing might be used as a risk assessment tool to identify parolees who demonstrate their higher criminal propensity by submitting positive urine samples early during parole. Regarding the strategy for drug testing, the evaluation recommends minimal surprise testing, but regular, frequent testing during the first 3 months of parole. 15 tables, 13 figures, and 44 references
Date Published: August 1, 1998
Downloads
Similar Publications
- Trends of Opioid Usage in Emergency Departments: An Analysis of Opioid Dispensing from 2019 to 2021
- Chemical Foundations for a Cannabis Breathalyzer
- Micro Solid Phase Extraction Surface-Enhanced Raman Spectroscopy (mu-SPE/SERS) Screening Test for the Detection of the Synthetic Cannabinoid JWH-018 in Oral Fluid